Yasunaga M - Search Results

1

Secretin prevents taurocholate-induced intrahepatic cholestasis in the rat.

Fukumoto Y, Ando M, Yasunaga M, Okuda M, Okita K. Fukumoto Y, et al. Among authors: yasunaga m. J Hepatol. 1994 Jun;20(6):750-4. doi: 10.1016/s0168-8278(05)80145-x. J Hepatol. 1994. PMID: 7930475

2

Effects of secretin on bile production in two kinds of cholestatic models by choledocho-caval fistula and bile duct ligation in rats.

Fukumoto Y, Ando M, Yasunaga M, Okuda M, Okita K. Fukumoto Y, et al. Among authors: yasunaga m. Gastroenterol Jpn. 1992 Jun;27(3):396-404. doi: 10.1007/BF02777760. Gastroenterol Jpn. 1992. PMID: 1624081

3

A new therapeutic trial of secretin in the treatment of intrahepatic cholestasis.

Fukumoto Y, Okita K, Yasunaga M, Konishi T, Yamasaki T, Ando M, Shirasawa H, Fuji T, Takemoto T. Fukumoto Y, et al. Among authors: yasunaga m. Gastroenterol Jpn. 1989 Jun;24(3):298-307. doi: 10.1007/BF02774328. Gastroenterol Jpn. 1989. PMID: 2663608 Clinical Trial.

4

Hepatocyte proliferation induced in rats by lead nitrate is suppressed by several tumor necrosis factor alpha inhibitors.

Kubo Y, Yasunaga M, Masuhara M, Terai S, Nakamura T, Okita K. Kubo Y, et al. Among authors: yasunaga m. Hepatology. 1996 Jan;23(1):104-14. doi: 10.1053/jhep.1996.v23.pm0008550029. Hepatology. 1996. PMID: 8550029

5

[Therapeutic effect of secretin on intrahepatic cholestasis. A case report].

Fukumoto Y, Okita K, Hino K, Shinkai Y, Yasunaga M, Ando M, Tanaka S, Fuji T, Takemoto T. Fukumoto Y, et al. Among authors: yasunaga m. Nihon Shokakibyo Gakkai Zasshi. 1988 Jul;85(7):1420-4. Nihon Shokakibyo Gakkai Zasshi. 1988. PMID: 3184512 Japanese. No abstract available.

6

Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation.

Masuhara M, Yasunaga M, Tanigawa K, Tamura F, Yamashita S, Sakaida I, Okita K. Masuhara M, et al. Among authors: yasunaga m. Hepatology. 1996 Aug;24(2):323-9. doi: 10.1053/jhep.1996.v24.pm0008690400. Hepatology. 1996. PMID: 8690400

7

Analysis of lymphoid follicles in liver of patients with chronic hepatitis C.

Hino K, Okuda M, Konishi T, Yamashita A, Kayano K, Kubota M, Yasunaga M, Fukumoto Y, Okita K. Hino K, et al. Among authors: yasunaga m. Liver. 1992 Dec;12(6):387-91. doi: 10.1111/j.1600-0676.1992.tb00593.x. Liver. 1992. PMID: 1470009

8

[Clinical trial of protease inhibitor in the treatment of fulminant hepatitis].

Yasunaga M, Mori K, Yamashita S, Okita K. Yasunaga M, et al. Nihon Rinsho. 1991 Sep;49(9):2120-4. Nihon Rinsho. 1991. PMID: 1960877 Japanese. No abstract available.

9

Clinical evaluation of glucagon and insulin in therapy of fulminant hepatitis.

Okita K, Matsuda S, Hanta T, Yasunaga M, Sanuki K, Takemoto T. Okita K, et al. Among authors: yasunaga m. Gastroenterol Jpn. 1987 Oct;22(5):607-13. doi: 10.1007/BF02776721. Gastroenterol Jpn. 1987. PMID: 3315819

10

The effect of E3330 on active oxygen generation by isolated hepatic macrophages in rats.

Wasaki S, Sakaida I, Nagatomi A, Matsumura Y, Yasunaga M, Okita K. Wasaki S, et al. Among authors: yasunaga m. J Gastroenterol. 1995 Apr;30(2):273-4. doi: 10.1007/BF02348678. J Gastroenterol. 1995. PMID: 7773361 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

388 results

Search Page

Filters